大洋生物：合计持股5%以上股东拟减持不超0.68%股份

Core Viewpoint - Wang Xiangao, a shareholder holding more than 5% of the shares, plans to reduce his holdings by up to 570,000 shares, representing 0.68% of the total shares, from January 12 to April 11, 2026, due to personal funding needs [1] Shareholder Information - As of the announcement date, Wang Xiangao holds 648,482 shares, which accounts for 0.77% of the company [1] - The shares to be reduced are sourced from shares acquired before the company's initial public offering and from capital reserve increases due to equity distribution [1] Impact on Company Control - The planned reduction in holdings does not pose a risk of changing the company's control [1]